THERAPEUTIC COMPOUNDS FOR OVARIAN CANCER

摘要

The present invention provides synthetic epitopes derived from the human melanoma antigen entaryotic mitiation factor 3 (eFF3), antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds, and immune effector cells raised in response to presentation of these epitopes. The invention further provides methods for inducing an immune response and administering immunotherapy to a subject by delivering the compositions of the invention.